CDH1 and ovarian cancer: Although E-cadherin is expressed in the vast majority of ovarian carcinomas there are some subtypes of ovarian cancer such as serous and clear cell carcinomas that have been reported to have weak to absent E-cadherin staining that is associated with cancer progression and more extensive peritoneal dissemination [59], [60], [61].